We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

2811:TSEKagome Co., Ltd. Analysis

Data as of 2026-05-28 - not real-time

¥2,559.50

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

Kagome trades at ¥2,560, below its 20‑day SMA of ¥2,578 and 50‑day SMA of ¥2,711, indicating a short‑term bearish bias. The RSI is around 41, neither overbought nor oversold, while the MACD histogram is positive (~6.8) and the signal line turned bullish, hinting at a possible near‑term reversal.
Valuation metrics show a trailing PE of ~15.9 versus a forward PE of ~11.5, and a price‑to‑book of 1.23, placing the stock near the lower end of its historical range. The dividend yield of 2.29% with a payout ratio under 30% appears sustainable given strong operating cash flow and ample cash on hand.
However, revenue growth is flat at 0.6% and operating margins are modest (~6%). Debt‑to‑equity stands at 37, and the 30‑day volatility of ~19% combined with decreasing volume adds a modest liquidity concern. The beta is essentially zero, reflecting minimal market‑wide price swings.
Overall, the stock offers a modest upside of about 7% to the analyst target of ¥2,750, while downside risk is limited by strong cash generation and defensive sector positioning.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • price near support at ¥2,513
  • bearish SMA hierarchy suggests downside pressure
  • positive MACD histogram indicates potential reversal

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • forward PE of ~11.5 signals valuation upside
  • stable dividend yield of 2.29% with low payout ratio
  • consumer defensive sector provides resilience

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • consistent dividend policy and cash generation
  • near‑zero beta limits market volatility exposure
  • manageable debt level supported by strong cash reserves

Key Metrics & Analysis

Financial Health

Revenue Growth0.60%
Profit Margin4.76%
P/E Ratio15.9
ROE7.70%
ROA3.92%
Debt/Equity36.92
P/B Ratio1.2
Op. Cash Flow¥27.7B
Free Cash Flow¥3.4B

Technical Analysis

TrendBearish
RSI41.2
Support¥2,513.00
Resistance¥2,734.00
MA 20¥2,576.78
MA 50¥2,710.57
MA 200¥2,782.11
MACDBullish
VolumeDecreasing
Fear & Greed Index91.52

Valuation

Target Price¥2,750.00
Upside/Downside7.44%
GradeFair
TypeBlend
Dividend Yield2.29%

Risk Assessment

Beta-0.01
Volatility19.25%
Sector RiskLow
Reg. RiskLow
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.